Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Chan

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Leukemia|November 7, 2021
Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemiaSeverine Cathelin, David Sharon, Amit Subedi, et al.
Nature Genetics|August 16, 2016
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolutionM Ryan Corces, Jason D Buenrostro, Beijing Wu, et al.
Cell Stem Cell|November 27, 2015
Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor DifferentiationClaire Mazumdar, Ying Shen, Seethu Xavy, et al.
Cell Stem Cell|July 22, 2021
Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasisAmit Subedi, Qiang Liu, Dhanoop M Ayyathan, et al.
Nature Communications|February 14, 2026
Blood-based epigenetic instability linked to human aging and diseaseSalman Basrai, Ido Nofech-Mozes, Rajesh Detroja, et al.
Science Advances|December 10, 2020
Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencingSagi Abelson, Andy G X Zeng, Ido Nofech-Mozes, et al.
Hematology (Amsterdam, Netherlands)|March 25, 2024
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native AsparaginaseMaria Agustina Perusini, Claire Andrews, Eshetu G Atenafu, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL RegimenRuiqi Chen, Xing Liu, Arjun D Law, et al.
British Journal of Haematology|May 13, 2020
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapyHassan Sibai, Ruiqi Chen, Xing Liu, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Leukemia|November 7, 2021
Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemiaSeverine Cathelin, David Sharon, Amit Subedi, et al.
Nature Genetics|August 16, 2016
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolutionM Ryan Corces, Jason D Buenrostro, Beijing Wu, et al.
Cell Stem Cell|November 27, 2015
Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor DifferentiationClaire Mazumdar, Ying Shen, Seethu Xavy, et al.
Cell Stem Cell|July 22, 2021
Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasisAmit Subedi, Qiang Liu, Dhanoop M Ayyathan, et al.
Nature Communications|February 14, 2026
Blood-based epigenetic instability linked to human aging and diseaseSalman Basrai, Ido Nofech-Mozes, Rajesh Detroja, et al.
Science Advances|December 10, 2020
Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencingSagi Abelson, Andy G X Zeng, Ido Nofech-Mozes, et al.
Hematology (Amsterdam, Netherlands)|March 25, 2024
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native AsparaginaseMaria Agustina Perusini, Claire Andrews, Eshetu G Atenafu, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL RegimenRuiqi Chen, Xing Liu, Arjun D Law, et al.
British Journal of Haematology|May 13, 2020
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapyHassan Sibai, Ruiqi Chen, Xing Liu, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
Pageof 7